Statement Of Cash Flows [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
2021-01-01 to 2021-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for decrease (increase) in trade and other receivables |
208,951,000
DKK
|
493,831,000
DKK
|
| Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss |
537,480,000
DKK
|
530,434,000
DKK
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
278,392,000
DKK
|
434,868,000
DKK
|
| Adjustments for undistributed profits of investments accounted for using equity method |
57,597,000
DKK
|
30,112,000
DKK
|
| Cash flows from (used in) financing activities [abstract] | ||
| Cash flows from (used in) increase (decrease) in current borrowings |
735,352,000
DKK
|
404,600,000
DKK
|